Recent News

By Region: North America

March of the pathogens: Parasite metabolism can foretell disease ranges under climate change

(EurekAlert) Knowing the temperatures that viruses, bacteria, worms and all other parasites need to grow and survive could help determine the future range of infectious diseases under climate change, according to new research. Princeton University researchers developed a model that can identify the prospects for nearly any disease-causing parasite as the Earth grows warmer, even Read More »

February 25, 2013
| Filed under North America and Research
Share

Chemical and Biological Defense Technologies BAA

(GlobalBiodefense) The U.S. military is seeking innovative ideas for development of technologies for chemical and biological defense applications under a Broad Agency Announcement (BAA) released this week by the Defense Threat Reduction Agency (DTRA) and the Joint Science and Technology Office for Chemical and Biological Defense (JSTO-CBD).

February 22, 2013
| Filed under North America, Biotechnology, and Research
Share

Dengue surges worldwide, hits United States and Europe

(FamilyPracticeNewsDigitalNetwork) Dengue infections surged to new worldwide highs last year, along with the first confirmed cases in Florida in more than 50 years, an ongoing outbreak on Europe’s doorstep on the island of Madeira, and a continued rise in cases elsewhere.

February 22, 2013
| Filed under Europe, North America, and Public Health
Share

Feds Set New Rules For Controversial Bird Flu Research

(NorthCountryPublicRadio) In early 2012, experiments that made H5N1 bird flu more contagious caused an uproar. People feared that mutant viruses could escape the lab and kill people. To prevent a repeat, the government has unveiled a policy describing how scientists should study dangerous pathogens and toxins.

February 22, 2013
| Filed under North America, Policy & Initiatives, and Research
Share

Scientists Conduct Human Trial of Two New Shigella Vaccines

(FoodSafetyNews) Scientists have begun a clinical trial of two vaccines that may prevent Shigella infection, announced the National Institutes of Health Wednesday. The government-funded study will examine the effect of two different but related vaccines on 90 healthy adults ages 18 to 45 years old.